Clinical trial · Observational
Radiotherapy for Thoracic and Breast Cancer and the Related Cardiotoxicity Following Treatment (RACCOON)
A Prospective Cohort Study of Patients Receiving Radiotherapy for Thoracic and Breast Cancer and the Related Cardiotoxicity Following Treatment (RACCOON)
NCT04674501CI-TRIAL-00049122unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the risk factors and mechanisms of cardiotoxicity following thoracic radiotherapy and to provide insights in preventing radiation-related cardiotoxicity. -Condition or disease : Thoracic irradiation -Intervention/treatment : Cardiac evaluation, Blood sampling
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Patients Who Receive Thoracic Irradiation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cardiac evaluation and blood sampling | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Thoracic irradiation
- description
- A cohort of cancer patients who receive thoracic irradiation. Patients with any type of malignancy, such as lung cancer, breast cancer, esophageal cancer, or thymoma, are eligible as long as the patients undergo thoracic irradiation.
- interventionNames
- Procedure: Cardiac evaluation and blood sampling
Primary outcomes (1)
- measure
- Cardiotoxicity rate
- timeFrame
- 2 years
Secondary outcomes (4)
- measure
- Overall survival
- timeFrame
- 2 years
- measure
- Cancer-specific survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with solid cancer who are subject to thoracic irradiation. 2. Patients who are 20 years old or older 3. Eastern Cooperative Oncology Group Performance Status Scale 0-2 4. Patients with cognitive abilities to receive virtual reality information Exclusion Criteria: 1. Patients with a history of previous thoracic irradiation 2. Patients who refused consent 3. Patients with a history of heart failure before radiotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.